Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin

Thrombopoietin (TPO) has been established as the major regulator of megakaryocyte and platelet production, In vitro and in vivo studies have demonstrated that TPO affects both megakaryocyte proliferation and maturation, In vitro, TPO has been reported to be essential for full development of megakaryocytes and platelets, These studies are in contrast to results observed in vivo in mice deficient in the TPO or c-mpl gene (TPO-/- and c-mpl-/-), Both TPO-/- and c-mpl-/-mice exhibit a 90% reduction in megakaryocyte and platelet levels. But even with this small number of circulating platelets, these mice do not have any excessive bleeding, Ultrastructural analysis indicates that platelets and megakaryocytes present in the knockout mice are morphologically normal. Characterization of platelet function shows that platelets from knockout mice are functionally identical to the wild-type platelets as measured by upregulation of I-125-fibrinogen binding to platelets in response to adenosine diphosphate (ADP) stimulation and by platelet attachment to the immobilized extracellular matrix proteins, collagen and von Willebrand factor (VWF). These results demonstrate that in vivo, TPO is required for the control of megakaryocyte and platelet number but not for their maturation, Other factors with megakaryocytopoietic activity may be able to compensate for the maturational role of TPO and lead to the formation of normal megakaryocytes and platelets in TPO-/- and c-mpl-/-mice. (C) 1997 by The American Society of Hematology.